Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series Session 2

More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder (OUD) in 2020.
However, fewer than one in five received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically.

This webinar series is a collaboration between all Quality Innovation Network-Quality Improvement Organizations and will provide strategies, interventions, and targeted solutions to ensure access to MOUD treatment and facilitate continuity of care through the continuum.

Session 2: Role of the Pharmacist in the Treatment of Patients with OUD

In this session, we will explain medication processes and address opioid adverse drug events (ADEs) and risk assessment for opioid prescribing.